ACORN CREEK CAPITAL LLC

Position in MRK — Merck & Co., Inc.

CIK 1994827 FORT COLLINS, CO

Position in MRK

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$243,507

+$8,220 QoQ

Shares Held

1,895

-3.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#3,367

of 3,769 holders

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ACORN CREEK CAPITAL LLC holds $3,422,772 across 6 Drug Manufacturers - General names. MRK ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,059	$1,270,196
2	NVS	Novartis AG	3,727	$584,095
3	ABBV	AbbVie Inc.	2,237	$562,918
4	JNJ	Johnson & Johnson	2,133	$541,718
5	MRK	Merck & Co., Inc. This page	1,895	$243,507
6	AZN	Astrazeneca PLC	1,162	$220,338

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$243,507	1,895	-3.1%	Shares	Sole	2026-08-06
2026-03-31	$235,287	1,956	-32.1%	Shares	Sole	2026-05-12
2025-03-31	$258,508	2,880	-31.3%	Shares	Sole	2025-04-22
2024-12-31	$417,219	4,194	-12.1%	Shares	Sole	2025-01-22
2024-09-30	$541,794	4,771	-2.4%	Shares	Sole	2024-10-15
2024-06-30	$605,258	4,889	-0.9%	Shares	Sole	2024-07-18
2024-03-31	$650,645	4,931	-3.1%	Shares	Sole	2024-04-24
2023-12-31	$554,584	5,087	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.